Published On: Nov 2022
Published On: Nov 2022
At 14.0% CAGR, the Middle East & Africa Neurosurgical Robotics Market is projected to be worth US$ 255.79 Million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Middle East & Africa neurosurgical robotics market was valued at US$ 116.23 million in 2022 and is expected to reach US$ 255.79 million by 2028, registering an annual growth rate of 14.0% from 2022 to 2028. Rising number of product developments and approvals including rising nanorobots technology are the critical factors attributed to the market expansion.
During the next 30 years, scientists are aiming to develop safe nanorobots for real-time interface tasks between the human brain and biological & nonbiological computing systems. It will lead to creation of brain-to-brain interfaces and brain–computer interfaces, in particular brain–cloud interfaces. Additionally, current preclinical studies are analyzing biocompatibility and security and adequate materials for nanorobot production. Thus, continuous research in nanorobots for neurosurgical procedures are expected to fuel the growth of the neurosurgical robotics market during the forecast period
On the contrary, high installation costs of neurosurgical robotics hurdles the growth of Middle East & Africa neurosurgical robotics market.
Our regional analysis states that the Rest of Middle East & Africa captured 38.9% market share in 2022. It was assessed at US$ 45.22 million in 2022 and is likely to hit US$ 96.54 million by 2028, exhibiting a CAGR of 13.5% during the forecast period.
Key players dominating the Middle East & Africa neurosurgical robotics market are Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Brain Navi Biotechnology Co., Ltd.; Globus Medical, Inc.; Medtronic; Renishaw plc; NuVasive, Inc.; and Zimmer Biomet.
Below are listed a few recent key developments by major market players:
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com